GeM Hosts Orientation Session for IDAS probationers on transforming public procurement (See 'Corp Brief') NHAI receives SEBI's in-irinciple approval for registration of Raajmarg Infra Investment Trust as InvIT (See 'Corp Brief') Centre okays Export Promotion Mission to Boost MSMEs & first-time Exporters (See 'Corp Brief') Govt lists steps taken to include AI-based diagnostic tools in healthcare (See 'Corp Brief') Govt reviews steps for upskilling & increase womens' participation in MSME sector (See 'Corp Brief') PM Vishwakarma Scheme - holistic support for artisans of 18 traditional trades; 23.09 Lakh beneficiaries trained (See 'Corp Brief') Govt notifies DPDP Act & Rules thereof; simplified framework for startups & data fiduciaries (See 'Corp Brief') SARFAESI - as per Sec 15 of the Act, if borrower's management is taken over by secured creditor, the management may be restored upon full repayment of debt: HC (See 'Legal Desk') Afforestation, ecological restoration - coal mining cos steps to ensure ecological balance (See 'Corp Brief') Competition Act - allegations primarily concerning contraventions of the Companies Act or Ministry of Youth Affairs and Sports directives, do not relate to anti-competitive conduct or violation of the Act: CCI (See 'Legal Desk') RBI issues guidelines for banks to provide customer services in regional languages (See 'Corp Brief') IBC - If bank has released approved payments from TRA account operated by them, then bank was monitoring these transactions during entire CIRP: IBBI (See 'Legal Desk') Govt releases Credit Assessment Model for MSMEs to enhance digitally driven loan appraisal (See 'Corp Brief') IBBI - Cannot be expected to maintain information with respect to other laws outside its purview: IBBI (See 'Legal Desk') Govt's aid measures for MSMEs - TReDS, Rs 9000 Crore infusion (See 'Corp Brief') Indian media & entertainment sector to maintain growth despite AI disruption: Secy (See 'Corp Brief') PBPT - Transactions are rightly deemed benami u/s 2(9)(D) of PBPTA, where person who provided consideration for properties was not traceable: SAFEMA Tribunal (See 'Legal Desk') Sustainable coal mining - Govt simplifies approval for geological exploration & reports (See 'Corp Brief') Benami - Benami transaction is considered not only in case of transfer of property by beneficial owner for his ultimate benefit in future, but even if such properties is held by benamidar: SAFEMA (See 'Legal Desk') IITF-2025 - FCI Pavilion showcasing modernised foodgrain management bags bronze medal (See 'Corp Brief') Copyright Act - Police have jurisdiction to register FIR u/s 33EEC of the Drugs and Cosmetics Act in conjunction with cognizable offence under Copyright Act; registration of copyright not mandatory for criminal proceedings upon infringement: HC (See 'Legal Desk') VO Chidambarnar port receives first Clinker vessel following MoU with Ambuja Cement Ltd (See 'Corp Brief') PMLA - Sweep of Sec 5(1) is not limited to accused named in criminal activity relating to scheduled offence, but shall apply equally to person who is involved in any activity connected with proceeds of crime: SAFEMA (See 'Legal Desk')

Print

'Cohort Connect 2025' to be India's Largest evidence-based study on Genetic

Published: Nov 14, 2025

By TIOLCorplaws News Service

NEW DELHI, NOV 14, 2025: ON the eve of World Diabetes Day tomorrow, Union Minister of State (Independent Charge) for Science & Technology, MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh today launched "Phenome National Conclave on Longitudinal Cohort Studies: Cohort Connect 2025", at CSIR–IMMT, here.

Cohort Connect is said to be India's largest evidence-based study on Genetic, Lifestyle and Environmental drivers of Disease.

Delivering the inaugural address, Dr. Jitendra Singh said that the discussion taking place a day before World Diabetes Day carries special relevance, as metabolic disorders like diabetes are rapidly emerging as a major national health challenge. He emphasised that diabetes today represents not just a clinical condition but a complete spectrum of vascular, neurological, and renal complications, making scientific research in this domain critical for national planning.

On the eve of World Diabetes Day, Dr. Jitendra Singh said that India's fight against diabetes and other rising metabolic disorders requires Indian data for Indian solutions, supported by long-term scientific evidence.

The Minister recalled that metabolic disorders, especially Type-2 diabetes, once considered region-specific, have now spread across the country due to lifestyle transitions and changing environmental patterns, turning what was earlier a South India–predominant condition into a pan-India challenge. He emphasized that India continues to deal simultaneously with both communicable and non-communicable diseases, and the reciprocal link between diabetes and infections such as tuberculosis requires integrated policy responses rather than compartmentalised programmes.

Dr. Jitendra Singh underscored that India's phenotypic uniqueness has been acknowledged for decades, but could never be scientifically validated due to limited genomic and epidemiological infrastructure. With initiatives like CSIR-led Phenome India and the large-scale longitudinal cohort studies being undertaken, India now can accurately capture how genetics, environment, diet, and lifestyle shape disease predisposition in Indian populations.

The Minister noted that even Indians living abroad for generations show distinctive susceptibility to metabolic disorders, highlighting the fundamental role of inherited traits.

The Minister shared clinical and historical insights illustrating how global medical understanding has evolved- from pre-insulin starvation-era diabetes management to today's genetic therapies, and urged caution in adopting new drugs and technologies without long-term evidence suited to Indian populations. He recalled that refined oils were once promoted as heart-friendly, only to be later linked with rising coronary artery disease in India, reinforcing the need for rigorous, long-term, India-specific studies before public health recommendations are made.

Highlighting Government initiatives, Dr. Jitendra Singh said that both CSIR and the Department of Biotechnology are working actively on human genome sequencing, with nearly 10,000 human genomes already sequenced and the target of one million genomes progressing rapidly. He also mentioned India's first successful haemophilia trial with indigenously developed Factor VIII, underscoring India's rising capabilities in advanced biomedical research.

Dr Jitendra Singh added that the Government is simultaneously working on vaccines for diseases like dengue, malaria, and tuberculosis, while AI-driven diagnostics, digital health platforms and quantum-enabled solutions are increasingly becoming part of India's medical ecosystem.

The Minister reiterated that with 70% of India's population below 40, prevention must be the central pillar of India's future health strategy. A robust cohort study ecosystem, he said, will generate actionable datasets for preventive, prophylactic and therapeutic pathways tailored to Indian needs. He appreciated CSIR institutions, project investigators, and private-sector partners for creating a platform that integrates science, evidence creation, and translational application through MoUs and venture collaborations.

Dr. Jitendra Singh concluded by stating that India's health status in 2047 will define the vision of Viksit Bharat, and scientific initiatives like Phenome India and Cohort Connect 2025 would serve as foundational pillars in achieving that goal. Citing Hippocrates, he said that even without tools or medicines, a doctor's knowledge can heal; similarly, India's collective scientific wisdom will drive its health transformation in the coming decades.

The inaugural session was attended by Dr. Ramanuj Narayan, Director, CSIR–IMMT, Dr. Maiti (CSIR–IGIB), Dr.Kooti, Dr. Debashish, senior scientists, project investigators, and media representatives. They briefed the press on the objectives and emerging insights from the Phenome India longitudinal cohort, along with the agenda of the upcoming National Conclave on Longitudinal Cohort Studies: Cohort Connect 2025, scheduled to be held at CSIR–IMMT, Bhubaneswar.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.